Search - tctmd.com

Displaying 1 - 20 of 38

Sort: Relevancy | Date

News Features

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

Michael O'Riordan

September 17, 2025

News Features

Once Burned, Twice Shy, Cardiologists Ditch X for Bluesky

Yael L. Maxwell

November 29, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Features

Chaos and Questions: New Public-Access Policies Put Journals in Flux

Michael O'Riordan

August 14, 2023

News Features

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

Todd Neale

October 17, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

News Features

Climate Cardiology: If Not Now, When?

Caitlin E. Cox

June 20, 2022

News Features

Sit Back, Relax . . . and Respond to an In-flight Medical Emergency?

Yael L. Maxwell

April 19, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Features

Unseen and Unheard: In the Cath Lab, Anti-racism Efforts Fall Short

L.A. McKeown

June 18, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Features

AI in Cardiology: Where We Are Now and Where to Go Next

Yael L. Maxwell

March 30, 2021

News Features

Low Numbers and ‘Anecdata’: Shoddy Research Rode COVID-19’s First Wave

Michael O'Riordan

January 11, 2021

News Features

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Shelley Wood

July 20, 2020

News Features

Stroke ‘Surge’ in the Young Fuels Debate Over COVID-19’s Culpability

Todd Neale

May 08, 2020

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Shelley Wood

April 29, 2020

News Features

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

Michael O'Riordan

March 03, 2020

News Features

The Cancer Patient Needing PCI Poses Conundrums for Care

Shelley Wood

January 14, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

Advertisement

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

Once Burned, Twice Shy, Cardiologists Ditch X for Bluesky

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Chaos and Questions: New Public-Access Policies Put Journals in Flux

Prudence or Spin? Mulling Embolic Protection After PROTECTED TAVR

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Climate Cardiology: If Not Now, When?

Sit Back, Relax . . . and Respond to an In-flight Medical Emergency?

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Unseen and Unheard: In the Cath Lab, Anti-racism Efforts Fall Short

Roughly 80% of ESC Guideline Writers Have Financial COIs

AI in Cardiology: Where We Are Now and Where to Go Next

Low Numbers and ‘Anecdata’: Shoddy Research Rode COVID-19’s First Wave

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Stroke ‘Surge’ in the Young Fuels Debate Over COVID-19’s Culpability

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

Trial by Twitter: How a 280-Character Count Is Reshaping Cardiology

The Cancer Patient Needing PCI Poses Conundrums for Care

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content